189 related articles for article (PubMed ID: 29065397)
21. Immunotherapy of hematological malignancies: what is new?
Ortín M
Ann Oncol; 2005; 16 Suppl 2():ii53-62. PubMed ID: 15958476
[No Abstract] [Full Text] [Related]
22. ALL and beyond: implications for other hematologic malignancies.
Thomas ED
Leukemia; 1997 May; 11 Suppl 4():S43-5. PubMed ID: 9179283
[No Abstract] [Full Text] [Related]
23. Preclinical and clinical development of inotuzumab-ozogamicin in hematological malignancies.
Shor B; Gerber HP; Sapra P
Mol Immunol; 2015 Oct; 67(2 Pt A):107-16. PubMed ID: 25304309
[TBL] [Abstract][Full Text] [Related]
24. Antibody-directed therapies for hematological malignancies.
Linenberger ML; Maloney DG; Bernstein ID
Trends Mol Med; 2002 Feb; 8(2):69-76. PubMed ID: 11815272
[TBL] [Abstract][Full Text] [Related]
25. Antibodies: Immunoconjugates and autologous cellular therapy in acute lymphoblastic leukemia.
Advani A
Best Pract Res Clin Haematol; 2015; 28(2-3):116-23. PubMed ID: 26590768
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibodies and immune therapies for adult precursor B-acute lymphoblastic leukemia.
Sikaria S; Aldoss I; Akhtari M
Immunol Lett; 2016 Apr; 172():113-23. PubMed ID: 26921100
[TBL] [Abstract][Full Text] [Related]
27. [Monoclonal antibody therapy: a literature review].
Del Debbio CB; Tonon LM; Secoli SR
Rev Gaucha Enferm; 2007 Mar; 28(1):133-42. PubMed ID: 17658067
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies and immunoconjugates in acute myeloid leukemia.
Amadori S; Stasi R
Best Pract Res Clin Haematol; 2006; 19(4):715-36. PubMed ID: 16997179
[TBL] [Abstract][Full Text] [Related]
29. Novel immunotherapies in lymphoid malignancies.
Batlevi CL; Matsuki E; Brentjens RJ; Younes A
Nat Rev Clin Oncol; 2016 Jan; 13(1):25-40. PubMed ID: 26525683
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy in adult acute leukemia.
Blum S; Martins F; Lübbert M
Leuk Res; 2017 Sep; 60():63-73. PubMed ID: 28756350
[TBL] [Abstract][Full Text] [Related]
31. Wilms' Tumor Gene 1 (WT1) Peptide Vaccine Therapy for Hematological Malignancies: From CTL Epitope Identification to Recent Progress in Clinical Studies Including a Cure-Oriented Strategy.
Oka Y; Tsuboi A; Nakata J; Nishida S; Hosen N; Kumanogoh A; Oji Y; Sugiyama H
Oncol Res Treat; 2017; 40(11):682-690. PubMed ID: 29041012
[TBL] [Abstract][Full Text] [Related]
32. Targeted therapy for hematologic malignancies.
Kuriakose P
Cancer Control; 2005 Apr; 12(2):82-90. PubMed ID: 15855891
[TBL] [Abstract][Full Text] [Related]
33. The immune system as a foundation for immunologic therapy and hematologic malignancies: a historical perspective.
Baron F; Storb R
Best Pract Res Clin Haematol; 2006; 19(4):637-53. PubMed ID: 16997174
[TBL] [Abstract][Full Text] [Related]
34. [The role of immunotherapy in the treatment of patients with hematologic neoplasms].
Rukavitsyn OA
Vopr Onkol; 2002; 48(2):186-92. PubMed ID: 12227066
[No Abstract] [Full Text] [Related]
35. The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemia.
DeAngelo DJ
Hematology Am Soc Hematol Educ Program; 2015; 2015():400-5. PubMed ID: 26637749
[TBL] [Abstract][Full Text] [Related]
36. Progress in the curative treatment of childhood hematologic malignancies.
Wayne AS; Reaman GH; Helman LJ
J Natl Cancer Inst; 2008 Sep; 100(18):1271-3. PubMed ID: 18780861
[No Abstract] [Full Text] [Related]
37. Programming the immune checkpoint to treat hematologic malignancies.
Vick E; Mahadevan D
Expert Opin Investig Drugs; 2016 Jul; 25(7):755-70. PubMed ID: 27070269
[TBL] [Abstract][Full Text] [Related]
38. Introduction: acute leukemia: recent advances.
Bloomfield CD; Herzig GP; Caligiuri MA
Semin Oncol; 1997 Feb; 24(1):1-2. PubMed ID: 9045295
[No Abstract] [Full Text] [Related]
39. Novel Therapies in Acute Lymphoblastic Leukemia.
Phelan KW; Advani AS
Curr Hematol Malig Rep; 2018 Aug; 13(4):289-299. PubMed ID: 30078158
[TBL] [Abstract][Full Text] [Related]
40. Second biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Bohlius J; Trelle S; Engert A
J Natl Cancer Inst; 2005 Apr; 97(7):E1. PubMed ID: 15812063
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
